Causes of false-positive HIV rapid diagnostic test results

References

• WHO. Rapid HIV Tests: Guidelines for Use in HIV Testing and Counseling Services in Resource-Constrained Settings. WHO, Geneva, Switzerland (2004).
   Google Scholar
• WHO/UNAIDS. HIV Rapid Assays: Operational Characteristics Report 16 Rapid Assays. WHO, Geneva, Switzerland (2009).
   Google Scholar
• WHO. Service Delivery Approaches to HIV Testing and Counselling (HTC), WHO, Geneva, Switzerland, 35–43 (2012).
   Google Scholar
• WHO. Global Programme on AIDS - recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol. Rec. 67(20), 145–152 (1992).
   PubMedGoogle Scholar
• Sato PA, Maskill WJ, Tamashiro H, Heymann DL. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot. Bull. World Health Organ. 72(1), 129–134 (1994).
   PubMed Web of Science ®Google Scholar
• CDC/WHO/APHL. Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. Centers for Disease Control and Prevention, World Health Organization, Geneva, Switzerland (2001).
   Google Scholar
• Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O’brien DP. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS ONE 4(2), e4351 (2009).
   PubMed Web of Science ®Google Scholar
• Kagulire SC, Opendi P, Stamper PD et al. Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda. Int. J. STD AIDS 22(6), 308–309 (2011).
   PubMed Web of Science ®Google Scholar
• Gray RH, Makumbi F, Serwadda D et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ 335(7612), 188 (2007).
   PubMed Web of Science ®Google Scholar
• Andrade VL, Avelleira JC, Marques A, Vianna FR, Schechter M. Leprosy as cause of false-positive results in serological assays for the detection of antibodies to HIV-1. Int. J. Lepr. Other Mycobact. Dis. 59(1), 125–126 (1991).
   PubMedGoogle Scholar
• Biggar RJ, Gigase PL, Melbye M et al. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 2(8454), 520–523 (1985).
   PubMed Web of Science ®Google Scholar
• Bracci L, Ballas SK, Spreafico A, Neri P. Molecular mimicry between the rabies virus glycoprotein and human immunodeficiency virus-1 GP120: cross-reacting antibodies induced by rabies vaccination. Blood 90(9), 3623–3628 (1997).
   PubMed Web of Science ®Google Scholar
• Buffington J, Shapiro CN, Holman RC et al. Multiple unconfirmed-reactive screening tests for viral antibodies among blood donors. Transfusion 34(5), 371–375 (1994).
   PubMed Web of Science ®Google Scholar
• Celum CL, Coombs RW, Jones M et al. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study. Arch. Intern. Med. 154(10), 1129–1137 (1994).
   PubMedGoogle Scholar
• Erickson CP, Mcniff T, Klausner JD. Influenza vaccination and false positive HIV results. N. Engl. J. Med. 354(13), 1422–1423 (2006).
   PubMed Web of Science ®Google Scholar
• Gasasira AF, Dorsey G, Kamya MR et al. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J. Clin. Microbiol. 44(8), 3021–3024 (2006).
   PubMed Web of Science ®Google Scholar
• Langedijk JP, Vos WF, Van Doornum GJ, Rotman HA, Meloen RH, Huisman JG. Identification of cross-reactive epitopes recognized by HIV-1 false-positive sera. AIDS 6(12), 1547–1548 (1992).
   PubMed Web of Science ®Google Scholar
• Shanks L, Klarkowski D, O’Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS ONE 8(3), e59906 (2013).
   PubMed Web of Science ®Google Scholar
• Branson BM. The future of HIV testing. J. Acquir. Immune Defic. Syndr. 55 (Suppl. 2), S102–S105 (2010).
   PubMed Web of Science ®Google Scholar
• WHO/UNAIDS. Operational Characteristics of Commercially Available Assays to Determine Antibodies to HIV-1 and/or HIV-2 in Human Sera. Reports 9/10. World Health Organization/the joint United Nations Programme on HIV/AIDS, Geneva, Switzerland (1998).
   Google Scholar
• WHO/UNAIDS. Operational Characteristics of Commercially Available Assays to Determine Antibodies to HIV-1 and/or HIV-2 in Human Sera. Reports 12. World Health Organization/the joint United Nations Programme on HIV/AIDS, Geneva, Switzerland (2002).
   Google Scholar
• WHO/UNAIDS. HIV Assays: Operational Characteristics Report 14 Simple/Rapid. WHO, Geneva, Switzerland (2004).
   Google Scholar
• Branson BM. Point-of-care rapid tests for HIV antibodies. J. Lab. Med. 27(7/8), 288–295 (2003).
   Google Scholar
• Clark JL, Coates TJ, Lescano AG et al. Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked immunosorbent assays. Clin. Vaccine Immunol. 13(2), 302–303 (2006).
   PubMedGoogle Scholar
• Tu XM, Litvak E, Pagano M. Issues in human immunodeficiency virus (HIV) screening programs. Am. J. Epidemiol. 136(2), 244–255 (1992).
   PubMed Web of Science ®Google Scholar
• Plate DK. Evaluation and implementation of rapid HIV tests: the experience in 11 African countries. AIDS Res. Hum. Retroviruses 23(12), 1491–1498 (2007).
   PubMed Web of Science ®Google Scholar
• Klarkowski D, Glass K, D. OB, Lokuge KM, Piriou E, Shanks L. Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a Bayesian Approach. PLoS ONE (2013) ( In Press).
   Web of Science ®Google Scholar
• Wagner BG, Blower S. Universal access to HIV treatment versus universal ‘test and treat’: transmission, drug resistance & treatment costs. PLoS ONE 7(9), e41212 (2012).
   PubMed Web of Science ®Google Scholar
• Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings. AIDS 24(5), 729–735 (2010).
   PubMed Web of Science ®Google Scholar
• Nicholson F, Best JM, Banatvala JE. HIV infection: risks of false positive serology. Br. Med. J. (Clin Res Ed) 296(6630), 1194 (1988).
   PubMed Web of Science ®Google Scholar
• The National Serology Reference Laboratory Australia. NRL’s Quality Assurance Programmes. National Serology Reference Laboratory, Victoria, Australia (2001).
   Google Scholar
• Marinovich A, Narlieva M, Bashir M, Zingman BS, Fox A. False-positive result from a Bayer Versant human immunodeficiency virus type 1 branched-DNA viral load assay, with a possible role for light leakage after inadequate maintenance of the analyzer. J. Clin. Microbiol. 44(11), 4288–4289 (2006).
   PubMed Web of Science ®Google Scholar
• Chappel RJ, Wilson KM, Dax EM. Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing. Future Microbiol. 4(8), 963–982 (2009).
   PubMed Web of Science ®Google Scholar
• Perry KR, Ramskill S, Eglin RP, Barbara JA, Parry JV. Improvement in the performance of HIV screening kits. Transfus. Med. 18(4), 228–240 (2008).
   PubMed Web of Science ®Google Scholar
• WHO. HIV testing and counseling policy framework. WHO, Geneva, Switzerland (2012).
   Google Scholar
• Laforgerie E, Boucher B, Ly TD et al. Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. J. Virol. Methods 165(1), 105–107 (2010).
   PubMed Web of Science ®Google Scholar
• Kroidl I, Clowes P, Mwalongo W et al. Low specificity of determine HIV1/2 RDT using whole blood in south west Tanzania. PLoS ONE 7(6), e39529 (2012).
   PubMed Web of Science ®Google Scholar
• Bouillon M, Aubin E, Roberge C, Bazin R, Lemieux R. Reduced frequency of blood donors with false-positive HIV-1 and -2 antibody EIA reactivity after elution of low-affinity nonspecific natural antibodies. Transfusion 42(8), 1046–1052 (2002).
   PubMed Web of Science ®Google Scholar
• Lejon V, Ngoyi DM, Ilunga M et al. Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness. J. Clin. Microbiol. 48(8), 2836–2839 (2010).
   PubMed Web of Science ®Google Scholar
• Tabarsi P, Moradi A, Baghaei P et al. Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy. Int. J. Tuberc. Lung Dis. 15(4), 547–550 (2011).
   PubMed Web of Science ®Google Scholar
• Brown M, Mawa PA, Kaleebu P, Elliott AM. Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunol. 28(11), 613–623 (2006).
   PubMed Web of Science ®Google Scholar
• Clerici M, Butto S, Lukwiya M et al. Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS 14(14), 2083–2092 (2000).
   PubMed Web of Science ®Google Scholar
• Clerici M, Declich S, Rizzardini G. African enigma: key player in human immunodeficiency virus pathogenesis in developing countries? Clin. Diagn. Lab. Immunol. 8(5), 864–866 (2001).
   PubMedGoogle Scholar
• Everett DB, Baisely KJ, Mcnerney R et al. Association of schistosomiasis with false-positive HIV test results in an African adolescent population. J. Clin. Microbiol. 48(5), 1570–1577 (2010).
   PubMed Web of Science ®Google Scholar
• Everett DB, Weiss HA, Changalucha J et al. Low specificity of the Murex fourth-generation HIV enzyme immunoassay in Tanzanian adolescents. Trop. Med. Int. Health 12(11), 1323–1326 (2007).
   PubMed Web of Science ®Google Scholar
• Everett DB, Baisley K, Changalucha J et al. Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings. J. Clin. Microbiol. 47(4), 1058–1062 (2009).
   PubMed Web of Science ®Google Scholar
• Naus CW, Kimani G, Ouma JH et al. Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age. Infect. Immun. 67(7), 3444–3451 (1999).
   PubMed Web of Science ®Google Scholar
• Naus CW, Jones FM, Satti MZ et al. Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum. J. Infect. Dis. 187(8), 1272–1282 (2003).
   PubMed Web of Science ®Google Scholar
• Fonseca MO, Pang L, De Avila Sdo L et al. Cross-reactivity of anti-Plasmodium falciparum antibodies and HIV tests. Trans. R. Soc. Trop. Med. Hyg. 94(2), 171–172 (2000).
   PubMed Web of Science ®Google Scholar
• Lien TX, Tien NT, Chanpong GF et al. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam. Am. J. Trop. Med. Hyg. 62(2), 301–309 (2000).
   PubMed Web of Science ®Google Scholar
• Crucitti T, Taylor D, Beelaert G, Fransen K, Van Damme L. Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clin. Vaccine Immunol. 18(9), 1480–1485 (2011).
   PubMedGoogle Scholar
• Messele T, Abdulkadir M, Fontanet AL et al. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin. Exp. Immunol. 115(3), 443–450 (1999).
   PubMed Web of Science ®Google Scholar
• Meles H, Wolday D, Fontanet A et al. Indeterminate human immunodeficiency virus Western blot profiles in ethiopians with discordant screening-assay results. Clin. Diagn. Lab. Immunol. 9(1), 160–163 (2002).
   PubMedGoogle Scholar
• Hill AV, Allsopp CE, Kwiatkowski D et al. Extensive genetic diversity in the HLA class II region of Africans, with a focally predominant allele, DRB1*1304. Proc. Natl Acad. Sci. USA 89(6), 2277–2281 (1992).
   PubMed Web of Science ®Google Scholar
• Cao K, Moormann AM, Lyke KE et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 63(4), 293–325 (2004).
   PubMedGoogle Scholar
• Alves C, Souza T, Meyer I, Toralles MB, Brites C. Immunogenetics and infectious diseases: special reference to the mayor histocompatibility complex. Braz. J. Infect. Dis. 10(2), 122–131 (2006).
   PubMedGoogle Scholar
• Santos Tde J, Costa CM, Goubau P et al. Western blot seroindeterminate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): a serological and molecular diagnostic and epidemiological approach. Braz. J. Infect. Dis. 7(3), 202–209 (2003).
   PubMedGoogle Scholar
• Ng VL. Serological diagnosis with recombinant peptides/proteins. Clin. Chem. 37(10 Pt 1), 1667–1668 (1991).
   PubMed Web of Science ®Google Scholar
• Branson BM. State of the art for diagnosis of HIV infection. Clin. Infect. Dis. 45 (Suppl. 4), S221–S225 (2007).
   PubMed Web of Science ®Google Scholar
• Cordes RJ, Ryan ME. Pitfalls in HIV testing. Application and limitations of current tests. Postgrad. Med. 98(5), 177–180, 185–176, 189 (1995).
   PubMed Web of Science ®Google Scholar
• Triulzi DJ, Kleinman S, Kakaiya RM et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 49(9), 1825–1835 (2009).
   PubMed Web of Science ®Google Scholar
• Samson L, King S. (The authors respond) False-positive results in antenatal HIV screening. CMAJ 160(9), 1285 (1999).
   PubMed Web of Science ®Google Scholar
• Magee LA, Murphy KE, Von Dadelszen P. False-positive results in antenatal HIV screening. CMAJ 160(9), 1285 (1999).
   PubMed Web of Science ®Google Scholar
• Doran TI, Parra E. False-positive and indeterminate human immunodeficiency virus test results in pregnant women. Arch. Fam. Med. 9(9), 924–929 (2000).
   PubMedGoogle Scholar
• Wesolowski LG, Delaney KP, Lampe MA, Nesheim SR. False-positive human immunodeficiency virus enzyme immunoassay results in pregnant women. PLoS ONE 6(1), e16538 (2011).
   PubMed Web of Science ®Google Scholar
• Mac Kenzie WR, Davis JP, Peterson DE, Hibbard AJ, Becker G, Zarvan BS. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 268(8), 1015–1017 (1992).
   PubMed Web of Science ®Google Scholar
• Simonsen L, Buffington J, Shapiro CN et al. Multiple false reactions in viral antibody screening assays after influenza vaccination. Am. J. Epidemiol. 141(11), 1089–1096 (1995).
   PubMed Web of Science ®Google Scholar
• Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89(2), 263–273 (1997).
   PubMed Web of Science ®Google Scholar
• Ribeiro TT, Brites C, Moreira ED Jr et al. Serologic validation of HIV infection in a tropical area. J. Acquir. Immune Defic. Syndr. 6(3), 319–322 (1993).
   PubMed Web of Science ®Google Scholar
• Pearlman ES, Ballas SK. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch. Pathol. Lab. Med. 118(8), 805–806 (1994).
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Loupi E, Blondeau C. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch. Pathol. Lab. Med. 119(8), 679 (1995).
   PubMed Web of Science ®Google Scholar
• Henderson S, Leibnitz G, Turnbull M, Palmer GH. False-positive human immunodeficiency virus seroconversion is not common following rabies vaccination. Clin. Diagn. Lab. Immunol. 9(4), 942–943 (2002).
   PubMedGoogle Scholar
• Araujo PR, Albertoni G, Arnoni C et al. Rubella vaccination and transitory false-positive test results for human immunodeficiency virus Type 1 in blood donors. Transfusion 49(11), 2516–2517 (2009).
   PubMed Web of Science ®Google Scholar
• Watt G, Chanbancherd P, Brown AE. Human immunodeficiency virus type 1 test results in patients with malaria and dengue infections. Clin. Infect. Dis. 30(5), 819 (2000).
   PubMed Web of Science ®Google Scholar
• Wai CT, Tambyah PA. False-positive HIV-1 ELISA in patients with hepatitis B. Am. J. Med. 112(9), 737 (2002).
   PubMed Web of Science ®Google Scholar
• Tesoro-Cruz E, Hernandez-Gonzalez R, Kretschmer-Schmid R, Aguilar-Setien A. Cross-reactivity between caprine arthritis-encephalitis virus and type 1 human immunodeficiency virus. Arch. Med. Res. 34(5), 362–366 (2003).
   PubMed Web of Science ®Google Scholar
• Jamjoon GA, Maatouk J, Gazal M et al. Follow-up of HIV western blot undeterminate results. Saudi Med. J. 17(3), 518–521 (1997).
   Google Scholar
• Salinas A, Gorgolas M, Fernandez-Guerrero M. Refrain from telling bad news: patients with leishmaniasis can have false-positive HIV test results. Clin. Infect. Dis. 45(1), 139–140 (2007).
   PubMed Web of Science ®Google Scholar
• Muller WE, Bachmann M, Weiler BE et al. Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro. J. Acquir. Immune Defic. Syndr. 4(7), 694–703 (1991).
   PubMed Web of Science ®Google Scholar
• Elm JD, Diwan A. Serological cross-reactivities between the retroviruses HIV and HTLV-1 and the malaria parasite Plasmodium falciparum. PNG Med. J. 41(1), 15–22 (1998).
   PubMedGoogle Scholar
• Fiori PL, Rappelli P. Do anti-Tricomonas vaginalis antibodies recognize HIV gp41? AIDS 14(13), 2057–2058 (2000).
   PubMed Web of Science ®Google Scholar
• Khalife J, Grzych JM, Pierce R et al. Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni. J. Exp. Med. 172(3), 1001–1004 (1990).
   PubMed Web of Science ®Google Scholar
• Craske J, Turner A, Abbott R et al. Comparison of false-positive reactions in direct-binding anti-HIV ELISA using cell lysate or recombinant antigens. Vox Sang. 59(3), 160–166 (1990).
   PubMed Web of Science ®Google Scholar
• Weber B, Gurtler L, Thorstensson R et al. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J. Clin. Microbiol. 40(6), 1938–1946 (2002).
   PubMed Web of Science ®Google Scholar
• Branson BM, Stekler JD. Detection of acute HIV infection: we can’t close the window. J. Infect. Dis. 205(4), 521–524 (2012).
   PubMed Web of Science ®Google Scholar
• Zeh C, Oyaro B, Vandenhoudt H et al. Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya. J. Virol. Methods 176(1–2), 24–31 (2011).
   PubMed Web of Science ®Google Scholar
• Delaney KP, Branson BM, Uniyal A et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin. Infect. Dis. 52(2), 257–263 (2011).
   PubMed Web of Science ®Google Scholar
• Molesworth AM, Ndhlovu R, Banda E et al. High accuracy of home-based community rapid HIV testing in rural Malawi. J. Acquir. Immune Defic. Syndr. 55(5), 625–630 (2010).
   PubMed Web of Science ®Google Scholar
• Piwowar-Manning E, Fiamma A, Laeyendecker O et al. HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). BMC Infect. Dis. 11, 251 (2011).
   PubMed Web of Science ®Google Scholar
• Lyamuya EF, Aboud S, Urassa WK et al. Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infect. Dis. 9, 19 (2009).
   PubMed Web of Science ®Google Scholar
• Eller LA, Eller MA, Ouma BJ et al. Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population. J. Clin. Microbiol. 45(10), 3281–3285 (2007).
   PubMed Web of Science ®Google Scholar
• Singer DE, Kiwanuka N, Serwadda D et al. Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays. J. Clin. Microbiol. 43(10), 5312–5315 (2005).
   PubMed Web of Science ®Google Scholar
• Aghokeng AF, Ewane L, Awazi B et al. Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon. J. Acquir. Immune Defic. Syndr. 37(5), 1632–1640 (2004).
   PubMed Web of Science ®Google Scholar
• Meless H, Tegbaru B, Messele T et al. Evaluation of rapid assays for screening and confirming HIV-1 infection in Ethiopia. Ethiop. Med. J. 40(Suppl. 1), 27–36 (2002).
   PubMedGoogle Scholar
• Pascoe SJ, Langhaug LF, Mudzori J, Burke E, Hayes R, Cowan FM. Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. AIDS Patient Care STDS 23(7), 571–576 (2009).
   PubMed Web of Science ®Google Scholar
• Yu SK, Fong CK, Landry ML, Hsiung GD, Solomon LR. A false positive HIV antibody reaction due to transfusion-induced HLA-DR4 sensitization. N. Engl. J. Med. 320(22), 1495–1496 (1989).
   PubMed Web of Science ®Google Scholar
• Kuhnl P, Seidl S, Holzberger G. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet 1(8439), 1222–1223 (1985).
   PubMed Web of Science ®Google Scholar
• Novick DM, Des Jarlais DC, Kreek MJ et al. Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease. Alcohol Clin. Exp. Res. 12(5), 687–690 (1988).
   PubMed Web of Science ®Google Scholar
• Steckelberg JM, Cockerill FR 3rd. Serologic testing for human immunodeficiency virus antibodies. Mayo Clin. Proc. 63(4), 373–380 (1988).
   PubMed Web of Science ®Google Scholar
• Argos P. A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO J. 8(3), 779–785 (1989).
   PubMed Web of Science ®Google Scholar
• Sherman MP, Dock NL, Ehrlich GD et al. Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses. AIDS Res. Hum. Retroviruses 11(3), 409–414 (1995).
   PubMed Web of Science ®Google Scholar
• Manca N, Graifenberghi S, Colombrita D. Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients. Eur. J. Epidemiol. 6(2), 201–206 (1990).
   PubMed Web of Science ®Google Scholar